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Recurrent Leukemia Cutis in Acute Myeloblastic Leukemia
Reda E. Girgis, MD,* Howard Terebelo, DO,^ and Koichi Maeda, MD*

We report the case of a 64-year-old female with acute myeloblastic leukemia (French-AmericanBritish classification: M2) who developed two specific cutaneous manifestations during her illness.
She presented with extensive cellulitis involving the face, neck, and upper chest wall. While the
cellulitis resolved with antibiotic therapy, afungating ulcerated nodule remained on the lower lip
which proved to be leukemic on biopsy. Concomitant blood and bone marrow findings were diagnostic
of acute myeloblastic leukemia. The lip lesion cleared with a course of chemotherapy. An
erythematous macular rash subsequently developed over the lower trunk which was thought to be an
allergic reaction to the penicillin treatment. However biopsy results were consistent with leukemia
cutis. A repeat bone marrow examination revealed excessive blasts. Our observations emphasize the
various presentations of leukemia cutis and the need to biopsy any cutaneous lesion of unclear etiology
in the setting of aciOe leukemia. (Henry Ford Hosp MedJ 1989:37.76-8)

A

variety of cutaneous manifestations have been described in
association with leukemia. Most of these are nonspecific
lesions, such as petechiae, ecchymosis, pyoderma, erythema
multiforme, bullous pemphigoid, and hyperpigmentation, as
well as nonspecific maculopapular and eczematous eruptions
(1). Various bacterial and mycotic skin infections are common
secondary to the immunosuppression inherent to the disease as
well as to that induced by chemotherapy. Herpes zoster and unusually large necrotic ulcers of herpes simplex are frequently
seen with leukemia (2). Leukemia cutis, in which the skin is infiltrated with leukemic cells, is less common. Its incidence varies according to the type of leukemia. Leukemia cutis occurs in
approximately one-third of padents with the monocytic varieties
(3) but is rare in acute granulocytic leukemia, with an incidence
of less than 5% (2,4,5). Specific lesions usually take the form of
papules, nodules, and plaques that are firm, discrete, and pink to
purple to reddish brown in color. They vary in size from a few
millimeters to solitary lesions of up to 15 cm in diameter (2,6).
Macules and ulcers are less frequent (7). The lesions may be
hemorrhagic or may blanch on pressure (8). Histologically, infiltrates begin around dermal blood vessels and dermal appendages which remain undisturbed but may be invaded and destroyed later. The epidermis generally remains intact (6).
Chloroma, or granulocytic sarcoma, is a green tumor composed
of immature granulocytic cells and the only pathognomonic lesion of acute granulocytic leukemia. The green color is due to
the presence of myeloperoxidase (1). The lesions of leukemia
cutis may progress or regress, either spontaneously or as a result
of therapy (6).
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Leukemia cutis usually appears after systemic leukemia is diagnosed but may be seen concomitantly or prior to the diagnosis. It has also been described with normal blood and bone
marrow findings (9). One report described the occurrence of leukemia cuds after complete remission of acute myelomonocytic
leukemia at a time when bone marrow findings revealed no evidence of recurrence (10). These authors supported the hypothesis that the skin may provide a sanctuary for malignant cells
during systemic chemotherapy (11).
In acute leukemia, specific cutaneous infiltrates are more
often associated with a larger leukemic burden (8,9). One study
suggested that leukemia cuds is associated with an adverse prognosis (7).

Case Report
A 64-year-old female presented on November 7, 1988, with extensive cellulitis involving the face, neck, and upper chest wall. Physical
examination revealed a temperature of 39°C (I02.2°F), mild
splenomegaly, and candidal vaginitis. Hemoglobin was 79 g/L (7.9 g/
dL), hematocrit 0.23 (23.4%), mean corpuscular volume 97 f L , re-
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I
Fig 2—Leukemia

cutis in the form of macular

rash.

Fig I—Skin biopsy showing inflltration of dermis with leukemic
cells (hematoxylin-eosin stain, 70X).
ticulocyte count 0.6%, platelet count 115,000/JJLL, and leukocyte count
6.1 X 10V|xL with a differential of 57 polymorphonuclear neutrophils,
18 bands, 13 lymphocytes, 6 monocytes, 1 atypical lymphocyte, 2
metamyelocytes, and 3 myelocytes. Antimicrobial therapy included a
one-week course of nafcillin. Subsequent peripheral blood smears revealed 10% blast forms wilh Auer bodies. The leukocyte count never
exceeded 10 x 10V|xL throughout the course of her illness. Bone marrow examination was diagnostic for acute myeloblastic leukemia
(French-American-British ciassitication: M2, acute nonlymphobla.stic
leukemia), with 16% myeloblasts and an overall cellularity of 90%. Almost 85% of the cells stained positive with Sudan black B stain, 76%
showed specific granules with alphanaphthol acetate esterase stain, and
14% were positive for butyrate activity (nonspecific esterase). The cellulitis resolved with antibiotic therapy, but a fungating noduloulcerative
lesion persisted on the lower lip. Biopsy of this lesion revealed atypical
cells which stained positively with chloroacetate e.sterase stain, indicating an origin from the myeloid senes (Fig I). A course of high-dose
cytosine-arabinoside (ara-C) was started on November 23, 1988. The
lip nodule improved dramatically and soon disappeared. On November
27th, the patient again developed a high fever, and antibiotic therapy
including mezlocillin was instituted. Eight days later, an erythematous
macular rash developed over the flanks, lower abdomen, and upper
thighs (Fig 2). The rash was nonpruritic and blanched on pressure. The
clinical impression was that of a drug reaction secondary to penicillin,
and a dermatology consultation concurred with this impression. A
punch biopsy was taken to rule out leukemia cutis. The mezlocillin was
stopped, and the macules coalesced into large patches which quickly
faded, leaving a ruddy brown discoloration. Biopsy revealed leukemic
infiltrate (Fig 3). A subsequent bone marrow examination revealed 18%
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Fig 3—High power view of biopsy taken from skin rash showing
cluster of atypical cells which stained positive with chloroacetate esterase stain.
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blasts with an overall cellularity of 5% to 7%. The patient underwent a
second course of inducdon chemotherapy with ara-C combined with
mitoxantrone. During this period, adherent whitish plaques developed
on the hard palate which sloughed leaving multiple, large, chronic ulcers. Biopsy revealed chronic inflammation without malignant cells.
Viral culture was positive for herpes simplex I . A third bone marrow
examination showed complete remission.

Discussion
This case illustrates the wide spectrum of specific and nonspecific cutaneous lesions that may occur in acute myeloblasdc
leukemia. Our patient developed two disdnct manifestations of
leukemia cuds. Neither of these lesions were grossly characterisdc of leukemia, and biopsy with cytochemical staining
techniques was required for accurate diagnosis. The macular
rash was particularly deceptive, masquerading as an allergic
drug reaction. Its occurrence after a course of chemotherapy
served as a marker, foretelling the presence of incomplete remission. Our observations emphasize the need to biopsy skin lesions of unclear origin in the setting of leukemia.
Our padent also had multiple mucocutaneous infecdons.
Clinicians should suspect an immunosuppressive disorder such
as leukemia when confronted with an otherwise unexplained
skin infecdon.
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The presence of leukemia cutis may portend an adverse prognosis. Our padent remains in remission on maintenance chemotherapy ten months after inidal remission.
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